Profile data is unavailable for this security.
About the company
SyntheticMR AB (publ) is a Sweden-based company that develops and markets software solutions for Magnetic Resonance Imaging (MRI). The Company provides SyMRI, which measures the absolute properties of the brain and delivers adjustable contrast images, automatic biomarker segmentation and quantitative data in a single MR scan. The SyMRI product is available in different packages. SyMRI IMAGE provides fast MRI workflows, allowing high patient throughput. SyMRI NEURO enables automatic segmentation of brain tissue, providing objective decision support. SyMRI Research Edition includes exportable SyMaps, parametric common contrast weighted images and maps of the brain, allowing the investigation to be taken even further. SyMRI is a registered trademark in Europe and in the USA.
- Revenue in SEK (TTM)81.53m
- Net income in SEK4.72m
- Incorporated2007
- Employees43.00
- LocationSyntheticMR AB (publ)Storgatan 11LINKOPING 582 23SwedenSWE
- Phone+46 13101650
- Websitehttps://www.syntheticmr.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortoma AB | 43.22m | -30.78m | 298.26m | 7.00 | -- | 1.97 | -- | 6.90 | -0.8112 | -0.8112 | 1.24 | 4.67 | 0.2294 | 1.01 | 4.49 | 6,173,962.00 | -16.34 | -10.45 | -17.53 | -11.64 | 86.83 | 339.86 | -71.22 | -175.52 | 3.04 | -- | 0.00 | -- | -- | -- | -38.87 | -- | 14.14 | -- |
| Micropos Medical AB (publ) | 2.68m | -22.68m | 299.38m | 9.00 | -- | 13.72 | -- | 111.67 | -0.2463 | -0.2463 | 0.022 | 0.1341 | 0.0994 | 0.1315 | 1.20 | 335,122.50 | -84.10 | -64.24 | -111.33 | -82.27 | 79.96 | 114.76 | -845.91 | -767.57 | 3.18 | -- | 0.0184 | -- | 50.23 | 5.94 | -26.57 | -- | -- | -- |
| Acarix AB | 6.26m | -70.95m | 302.73m | 9.00 | -- | 4.41 | -- | 48.38 | -0.1168 | -0.1168 | 0.0095 | 0.0697 | 0.0894 | 0.1172 | 2.47 | -- | -101.38 | -66.93 | -123.43 | -77.12 | 88.27 | 79.42 | -1,133.87 | -1,483.68 | 5.21 | -328.98 | 0.00 | -- | 7.20 | 43.55 | -1.11 | -- | -- | -- |
| INIFY Laboratories AB | 3.42m | -51.43m | 322.69m | 23.00 | -- | 4.67 | -- | 94.30 | -1.18 | -1.18 | 0.0787 | 1.68 | 0.032 | 2.99 | 0.6608 | -- | -48.10 | -- | -48.10 | -- | 76.42 | -- | -1,503.10 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Karolinska Development AB | 1.90m | -5.65m | 325.45m | 8.00 | -- | 0.2565 | -- | 171.02 | -0.0209 | -0.0209 | 0.007 | 4.56 | 0.0015 | -- | 1.38 | 237,875.00 | -0.4536 | 3.37 | -0.4578 | 3.83 | -- | -- | -296.85 | 1,466.36 | -- | -- | 0.0021 | 0.00 | -12.43 | -8.10 | 106.11 | -29.31 | -- | -- |
| Boule Diagnostics AB | 572.53m | 21.28m | 341.62m | 230.00 | 16.36 | 0.6871 | 7.20 | 0.5967 | 0.5368 | 0.5368 | 14.45 | 12.78 | 0.724 | 4.19 | 3.69 | 2,511,092.00 | 2.68 | 1.67 | 3.71 | 2.40 | 43.86 | 43.50 | 3.70 | 2.04 | 0.9268 | 4.72 | 0.2698 | 42.24 | 4.24 | 6.13 | 96.24 | -9.45 | -9.74 | -- |
| Q linea AB | 4.70m | -224.61m | 385.95m | 99.00 | -- | 5.02 | -- | 82.20 | -2.06 | -2.06 | 0.0428 | 0.5813 | 0.0277 | 0.1707 | 11.86 | 36,968.50 | -132.70 | -59.66 | -356.93 | -66.14 | -56.25 | -378.58 | -4,783.96 | -4,046.97 | 0.6999 | -- | 0.4555 | -- | -65.28 | 33.02 | 14.64 | -- | 41.94 | -- |
| ContextVision AB | 132.39m | 25.69m | 415.02m | 41.00 | 14.76 | 4.22 | 12.05 | 3.13 | 0.3456 | 0.3456 | 1.78 | 1.21 | 1.21 | 2.33 | 4.81 | 3,444,860.00 | 23.39 | 29.39 | 30.67 | 43.27 | 97.39 | 98.58 | 19.40 | 27.15 | 3.99 | -- | 0.0304 | -- | 12.19 | 7.78 | -1.77 | -- | -35.88 | -- |
| BrainCool AB (publ) | 32.23m | -57.17m | 489.00m | 20.00 | -- | 2.98 | -- | 15.17 | -0.2685 | -0.2685 | 0.1501 | 0.6527 | 0.2253 | 2.04 | 2.85 | 1,343,042.00 | -39.96 | -47.14 | -44.79 | -70.16 | -37.24 | -149.77 | -177.38 | -391.45 | 4.16 | -6.19 | 0.00 | -- | 32.06 | 78.35 | -34.34 | -- | -11.63 | -- |
| SyntheticMR AB (publ) | 81.53m | 4.72m | 491.46m | 43.00 | 115.52 | 4.82 | 43.31 | 6.03 | 0.1134 | 0.1134 | 1.96 | 2.72 | 0.6049 | -- | 1.53 | 2,203,514.00 | 3.50 | 7.19 | 4.24 | 8.85 | 70.27 | 69.70 | 5.79 | 9.08 | -- | 18.00 | 0.0066 | 21.50 | 30.67 | 13.05 | 70.34 | -7.33 | 27.30 | -- |
| Integrum AB | 102.18m | -2.52m | 533.30m | 36.00 | -- | 2.80 | 703.63 | 5.22 | -0.1244 | -0.1244 | 5.29 | 9.58 | 0.5706 | 0.5666 | 3.59 | 2,620,068.00 | -1.41 | -1.71 | -1.55 | -1.98 | 87.25 | 83.87 | -2.47 | -2.87 | 5.54 | -0.6636 | 0.0325 | -- | 40.19 | 35.91 | 124.92 | -- | 127.10 | -- |
| Modulight Oyj | 38.85m | -133.48m | 547.08m | 79.00 | -- | 0.9021 | -- | 14.08 | -0.2844 | -0.2844 | 0.0836 | 1.22 | 0.0516 | -0.3111 | 1.94 | 49,271.43 | -17.72 | -8.39 | -18.97 | -9.10 | 123.49 | 114.69 | -343.58 | -56.81 | 4.50 | -- | 0.0965 | -- | -12.48 | -8.20 | -38.69 | -- | 63.60 | -- |
| Bioretec Oy | 45.91m | -39.76m | 599.32m | 43.00 | -- | 8.65 | -- | 13.05 | -0.1752 | -0.1752 | 0.2024 | 0.318 | 0.4104 | 1.23 | 3.75 | 110,166.80 | -35.54 | -66.83 | -40.92 | -97.19 | 69.97 | 70.97 | -86.61 | -133.49 | 4.04 | -- | 0.0696 | -- | 32.78 | 19.77 | -54.02 | -- | -- | -- |
| Gentian Diagnostics ASA | 140.56m | -1.93m | 674.68m | 58.00 | -- | 4.21 | 96.81 | 4.80 | -0.1369 | -0.1369 | 9.43 | 10.20 | 0.7756 | 1.71 | 6.79 | 2,522,379.00 | -1.07 | -10.76 | -1.21 | -11.86 | 51.06 | 41.46 | -1.37 | -26.99 | 4.83 | -- | 0.047 | -- | 32.98 | 27.63 | 54.92 | -- | -4.92 | -- |
| OssDsign AB | 123.46m | -113.80m | 679.17m | 27.00 | -- | 2.91 | -- | 5.50 | -1.40 | -1.40 | 1.43 | 2.30 | 0.4311 | 2.50 | 6.80 | 2,572,083.00 | -39.74 | -37.92 | -43.39 | -43.56 | 83.94 | 68.10 | -92.18 | -203.06 | 5.92 | -21.65 | 0.0114 | -- | 96.84 | 53.26 | -31.30 | -- | -56.16 | -- |
Data as of Sep 27 2024. Currency figures normalised to SyntheticMR AB (publ)'s reporting currency: Swedish Krona SEK
17.69%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Handelsbanken Fonder ABas of 31 Jul 2024 | 2.04m | 4.88% |
| Swedbank Robur Fonder ABas of 28 Jun 2024 | 1.94m | 4.66% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 28 Mar 2024 | 1.63m | 3.91% |
| Aktia Bank Plc (Investment Management)as of 28 Mar 2024 | 915.34k | 2.20% |
| Fondita Fund Management Co. Ltd.as of 30 Jun 2024 | 500.00k | 1.20% |
| Nordea Investment Management AB (Finland)as of 31 May 2024 | 295.09k | 0.71% |
| Axxion SA (Luxembourg)as of 28 Jun 2024 | 54.58k | 0.13% |
More ▼
Data from 31 May 2024 - 31 Jul 2024Source: FactSet Research Systems Inc.
